AU2003252459A1 - A platform for transdermal formulations (ptf) - Google Patents
A platform for transdermal formulations (ptf) Download PDFInfo
- Publication number
- AU2003252459A1 AU2003252459A1 AU2003252459A AU2003252459A AU2003252459A1 AU 2003252459 A1 AU2003252459 A1 AU 2003252459A1 AU 2003252459 A AU2003252459 A AU 2003252459A AU 2003252459 A AU2003252459 A AU 2003252459A AU 2003252459 A1 AU2003252459 A1 AU 2003252459A1
- Authority
- AU
- Australia
- Prior art keywords
- composition according
- patch
- ptf
- oily emulsion
- composition
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
Landscapes
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Dermatology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Tropical Medicine & Parasitology (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE10228680.9 | 2002-06-27 | ||
| DE10228680A DE10228680A1 (de) | 2002-06-27 | 2002-06-27 | Grundlage für transdermale Formulierungen (PTF) |
| PCT/IB2003/003467 WO2004002444A2 (en) | 2002-06-27 | 2003-06-21 | A platform for transdermal formulations (ptf) |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AU2003252459A1 true AU2003252459A1 (en) | 2004-01-19 |
Family
ID=29761469
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU2003252459A Abandoned AU2003252459A1 (en) | 2002-06-27 | 2003-06-21 | A platform for transdermal formulations (ptf) |
Country Status (14)
| Country | Link |
|---|---|
| US (1) | US20050118241A1 (cg-RX-API-DMAC7.html) |
| EP (1) | EP1515706A2 (cg-RX-API-DMAC7.html) |
| JP (1) | JP2005535635A (cg-RX-API-DMAC7.html) |
| KR (1) | KR20050027995A (cg-RX-API-DMAC7.html) |
| CN (1) | CN1665492A (cg-RX-API-DMAC7.html) |
| AR (1) | AR040287A1 (cg-RX-API-DMAC7.html) |
| AU (1) | AU2003252459A1 (cg-RX-API-DMAC7.html) |
| CA (1) | CA2490022A1 (cg-RX-API-DMAC7.html) |
| DE (1) | DE10228680A1 (cg-RX-API-DMAC7.html) |
| MX (1) | MXPA04012732A (cg-RX-API-DMAC7.html) |
| MY (1) | MY157852A (cg-RX-API-DMAC7.html) |
| TW (1) | TW200500093A (cg-RX-API-DMAC7.html) |
| WO (1) | WO2004002444A2 (cg-RX-API-DMAC7.html) |
| ZA (1) | ZA200500710B (cg-RX-API-DMAC7.html) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7033998B2 (en) * | 2003-04-11 | 2006-04-25 | All Natural Fmg, Inc. | Alcohol-free transdermal insulin composition and processes for manufacture and use thereof |
| US7396819B2 (en) * | 2003-08-08 | 2008-07-08 | Virbac Corporation | Anthelmintic formulations |
| WO2005094210A2 (en) * | 2004-03-12 | 2005-10-13 | The Hartz Mountain Corporation | Multi-action anthelmintic formulations |
| US10042980B2 (en) | 2005-11-17 | 2018-08-07 | Gearbox Llc | Providing assistance related to health |
| US20110145009A1 (en) * | 2005-11-30 | 2011-06-16 | Jung Edward K Y | Methods and systems related to transmission of nutraceutical associatd information |
| US10296720B2 (en) | 2005-11-30 | 2019-05-21 | Gearbox Llc | Computational systems and methods related to nutraceuticals |
| US20120283332A1 (en) * | 2009-05-12 | 2012-11-08 | Ohio University | Transdermal delivery of metformin |
| US10363229B2 (en) | 2009-06-05 | 2019-07-30 | Joan McInyre Caron | Methods and compositions for the treatment of cancer |
| RU2659729C2 (ru) * | 2012-07-30 | 2018-07-03 | Матинас Биофарма Нанотекнолоджис, Инк. | Кохлеаты, полученные с использованием фосфатидилсерина сои |
Family Cites Families (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4878892A (en) * | 1987-02-10 | 1989-11-07 | Drug Delivery Systems Inc. | Electrolytic transdermal delivery of polypeptides |
| FR2616333A1 (fr) * | 1987-06-12 | 1988-12-16 | Cird | Procede d'ionophorese pour administrer une substance dissoute ou partiellement dissoute, par voie percutanee ou perungueale et dispositif correspondant |
| JPS63316737A (ja) * | 1987-06-19 | 1988-12-26 | Toyo Jozo Co Ltd | 経鼻投与用医薬組成物 |
| IT1223343B (it) * | 1987-11-03 | 1990-09-19 | Also Lab Sas | Formulazioni farmaceutiche per somministrazione transdermica |
| US5332577A (en) * | 1988-12-27 | 1994-07-26 | Dermamed | Transdermal administration to humans and animals |
| EP0429842B1 (en) * | 1989-10-27 | 1996-08-28 | Korea Research Institute Of Chemical Technology | Device for the transdermal administration of protein or peptide drug |
| US5073539A (en) * | 1990-01-22 | 1991-12-17 | Ciba-Geigy Corporation | Transdermal administration of zwitterionic drugs |
| DE69216836T2 (de) * | 1991-07-26 | 1997-06-12 | Smithkline Beecham Corp | W/o mikroemulsionen |
| FR2687321B1 (fr) * | 1992-02-14 | 1999-04-16 | Elf Aquitaine | Dispositif d'ionophorese pour l'administration transcutanee d'une quantite totale donnee d'un principe actif a un sujet. |
| WO1996010439A1 (en) * | 1994-09-30 | 1996-04-11 | Kabushiki Kaisya Advance | Interface for iontophoretic percutaneous administration, and agent and method for treating the skin for that purpose |
| US5707641A (en) * | 1994-10-13 | 1998-01-13 | Pharmaderm Research & Development Ltd. | Formulations comprising therapeutically-active proteins or polypeptides |
| US5759445A (en) * | 1995-05-24 | 1998-06-02 | Matsushita Electric Industrial Co., Ltd. | Lipid-dispersed solution and process for producing the same |
| US6183758B1 (en) * | 1998-01-29 | 2001-02-06 | Highland Laboratories, Inc. | Phytochemicals, nutrients & medication absorption &/or treatment |
| JP2002519366A (ja) * | 1998-07-07 | 2002-07-02 | トランスダーマル・テクノロジーズ・インコーポレーテツド | 医薬的に活性な作用物質を迅速かつ非刺激的に経皮送達するための組成物、およびそのような組成物の調剤法およびそれらの送達 |
| CA2369594A1 (en) * | 1999-05-07 | 2000-11-16 | Pharmasol Gmbh | Lipid particles on the basis of mixtures of liquid and solid lipids and method for producing same |
| US6309663B1 (en) * | 1999-08-17 | 2001-10-30 | Lipocine Inc. | Triglyceride-free compositions and methods for enhanced absorption of hydrophilic therapeutic agents |
-
2002
- 2002-06-27 DE DE10228680A patent/DE10228680A1/de not_active Withdrawn
-
2003
- 2003-06-21 US US10/511,463 patent/US20050118241A1/en not_active Abandoned
- 2003-06-21 CN CN038151030A patent/CN1665492A/zh active Pending
- 2003-06-21 JP JP2004517161A patent/JP2005535635A/ja active Pending
- 2003-06-21 CA CA002490022A patent/CA2490022A1/en not_active Abandoned
- 2003-06-21 WO PCT/IB2003/003467 patent/WO2004002444A2/en not_active Ceased
- 2003-06-21 AU AU2003252459A patent/AU2003252459A1/en not_active Abandoned
- 2003-06-21 MX MXPA04012732A patent/MXPA04012732A/es not_active Application Discontinuation
- 2003-06-21 EP EP03761748A patent/EP1515706A2/en not_active Withdrawn
- 2003-06-21 KR KR1020047021277A patent/KR20050027995A/ko not_active Withdrawn
- 2003-06-23 TW TW092116951A patent/TW200500093A/zh unknown
- 2003-06-24 MY MYPI20032357A patent/MY157852A/en unknown
- 2003-06-27 AR ARP030102324A patent/AR040287A1/es not_active Application Discontinuation
-
2005
- 2005-01-03 ZA ZA200500710A patent/ZA200500710B/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| WO2004002444A2 (en) | 2004-01-08 |
| CN1665492A (zh) | 2005-09-07 |
| TW200500093A (en) | 2005-01-01 |
| WO2004002444A3 (en) | 2004-03-11 |
| ZA200500710B (en) | 2005-09-05 |
| AR040287A1 (es) | 2005-03-23 |
| US20050118241A1 (en) | 2005-06-02 |
| MY157852A (en) | 2016-07-29 |
| CA2490022A1 (en) | 2004-01-08 |
| JP2005535635A (ja) | 2005-11-24 |
| MXPA04012732A (es) | 2005-11-17 |
| EP1515706A2 (en) | 2005-03-23 |
| DE10228680A1 (de) | 2004-01-22 |
| KR20050027995A (ko) | 2005-03-21 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US6274166B1 (en) | Transdermal delivery system | |
| AU2003238862B9 (en) | Formulations for amylin agonist peptides | |
| TWI685348B (zh) | 速效胰島素組合物 | |
| US7033998B2 (en) | Alcohol-free transdermal insulin composition and processes for manufacture and use thereof | |
| NZ263891A (en) | Pharmaceutical composition of progesterone and/or 17-beta-estradiol, the active ingredient(s) being dissolved in an oil that is the inner phase of an oil-water two-phase system | |
| US20050118241A1 (en) | Platform for transdermal formulations (ptf) | |
| RU2543635C2 (ru) | Способ и фармацевтические композиции для лечения постпрандиальной гипергликемии диабета ii типа введением через слизистую ротовой полости | |
| Fransson et al. | Transdermal absorption of a liposomeencapsulated formulation of lidocaine following topical administration in cats | |
| SK9062000A3 (en) | Transmucosal formulations of levosimendan | |
| US7291591B2 (en) | Alcohol-free transdermal insulin composition | |
| EP1079801A1 (en) | A pharmaceutical formulation for nasal administration | |
| US6667052B2 (en) | Transdermal delivery system | |
| KR100466757B1 (ko) | 생체에 펩티드성 약물을 유입시키기 위한 국소 제제 | |
| JP2002536337A (ja) | 麻酔の調節 | |
| Zimmer et al. | Noninvasive drug delivery | |
| JPS6045161B2 (ja) | 熱傷の治療剤 | |
| JPH01501708A (ja) | アミノ酸の経鼻投与 | |
| JPH0761942B2 (ja) | 血中尿酸濃度の低下用医薬 | |
| JPS6237017B2 (cg-RX-API-DMAC7.html) | ||
| KR930002093B1 (ko) | 단백질 의약품의 경구투여용 조성물 | |
| JPH06154287A (ja) | 治療装置 | |
| Higgins | Insulin delivery: will injections always be necessary? | |
| TAMAKI et al. | Intestinal Absorption of a New Anticholinergic Agent, Timepidium Bromide. II. Enhancement of Absorption | |
| JPH03128327A (ja) | モチリン製剤 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MK4 | Application lapsed section 142(2)(d) - no continuation fee paid for the application |